Scholars Central

Short communicationPublished 8 Sep 2020

Novel Technology on Neo-Two Cancers (Bladder and Prostate Cancers) Screening

Authors: Chong Li

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Prostate cancer is the second most commonly occurring cancer in men and the fourth most commonly occurring cancer overall. There were 1.3 million new cases in 2018. The top 20 countries with the highest rates of prostate cancer in 2018 include UK and France. The prostate cancer has become the second most common cancer of urinary system in China. Consequently, there’s no doubt that bladder cancer and prostate cancer have been two leading killers in urinary system, here, we define them as “neo two cancers” with “neo” prefixed to make it distinguished from women’s two most common cancers, breast cancer and cervical cancer. Early detection is the major challenge. We established a highly sensitive method to detect cancer antigen in urine using LS-MS-MS screening (US patent and published in Mol cancer, cancer+, Clin Cancer Res, Eur Urol, and Cancer Res). The goal of the study is to develop affordable, accurate and non-invasive technology available to the World through collaborations.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cancer & Metastasis Research
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Chong Li”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels